Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
Open | $34.900 |
Close | $34.540 |
Volume / Avg. | 807.894K / 760.645K |
Day Range | 33.630 - 35.480 |
52 Wk Range | 19.795 - 35.500 |
Market Cap | $1.961B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 74 |
Short Interest | 11.79% |
Days to Cover | 12.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Other companies in Agios Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Dyne Therapeutics (NASDAQ:DYN) and Inhibrx (NASDAQ:INBX).
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by Goldman Sachs on Friday, May 3, 2024. The analyst firm set a price target for 33.00 expecting AGIO to fall to within 12 months (a possible -4.46% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $34.54 last updated May 3, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Agios Pharmaceuticals.
Agios Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Agios Pharmaceuticals.
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.